Overview of Current Regulatory Practices, Challenges and Guidance for Regulation of Stem Cells and Stem Cell Derived Products in India
Journal Title: Journal of Regenerative Biology and Medicine - Year 2019, Vol 1, Issue 1
Abstract
Stem Cell Science/Regenerative Medicine is perhaps the most important "pillar" out of the four pillars of modern medicine. Use and abuse of the "Stem Cells and Stem Cell derived Products" as therapeutic measure for treatment of several untreatable diseases has come to the fore in recent times. The "stem cells" are drugs as discussed below. In the realm of clinical trials, to be approved by FDA, just as a "drug" undergoes trials, successively via phase I, phase II and phase III trials, likewise stem cells, which are "drugs" per se has to be channeled through the same three phases of clinical trials. There are some evolving regulations in place for regulating stem cell research and its prospective human application in clinical trials which is in place, as per the guidelines of ICSSR 2016. Each and every country, including India has more or less similar rules and regulations which conform to the rules/regulations as proposed by ICSSR and followed by FDA, although many countries has done individual modifications in the same. The role of NAC-SCRT, ICMR, IEC, IC-SCR, DCGI are clearly defined and it has been clearly stated in NGSCR that approval for stem cell application in patients, (Autologous, allogenic, homologous or non-homologous) only within the confines of "clinical trials" and therapy based on Stem Cells and Stem Cell derived Products (SCDP) should be informed in a proper format to the regulatory concern and done through the proper channel. All laboratories and institutes coming under the umbrella of NGSCR should have GMP, GLP and GCP compliant. Appropriate clean room classification shall be followed for stem cell isolation, culturing or manipulation in their respective lab/institutes. The safety and efficacy concerns regarding animal and human applications, uniformity in batch production, strengthening of scientific knowhow should definitely be in line with the cutting edge technological advancements globally. Conformity with international guidelines, and peer reviewed publications are a must for getting approval for clinical trials and marketing options. The review as a whole may not be comprehensive enough to include all the points in relation to the regulatory domain for approving SCDP in our country but an attempt has been made to identify the important points keeping in mind that this domain will evolve and rules and regulations will change with the passage of time.
Authors and Affiliations
Yogesh Shelar1, M. P. Venkatesh1, C. Hemanth Kumar2, Manoj Bansode3, Kaniska Mukherjee4, Kaushik Deb4*
Keywords
Related Articles
- EP ID EP707299
- DOI https://doi.org/10.37191/Mapsci-2582-385X-1(1)-001
- Views 140
- Downloads 1
Front-line Healthcare Workers in COVID-19: The way from Elbow-Bump Greeting to Closing Body Bags
COVID-19 is a serious coronavirus disease that is spreading all over the world. As of the date of this publication, 2.834.134 people have been infected with COVID-19 and 197.924 deaths have been recorded in 185 countries...
Overall Analysis of COVID-19 Pandemic in Germany
What The COVID-19 pandemic has been present in Germany since 27 January 2020, it is the spread of the respiratory disease COVID-19, which first appeared at the end of 2019 and broke out worldwide at the beginning of 2020...
Topical Beta Blockers in Small Infantile Hemangioma: State of the Art?
Infantile hemangiomas (IH) are benign forms of endothelial proliferation in the first 8 weeks of life [1-11]. Leaute-Labreze et al. published the first spontaneous cases of IH treated with beta blockers in 2008 due to th...
Effect of Salvestrol as an Adjunct in the Treatment of Head & Neck, GIT, Ovary, Breast and Lung Malignancies Undergoing Conventional Treatment in an Indian Population
Background: Previous studies have elucidated that Salvestrols are a class of phytonutrients that, function through an extremely targeted mechanism that hinges on their metabolism by the universal cancer marker CYP1B1, ca...
Overview of Current Regulatory Practices, Challenges and Guidance for Regulation of Stem Cells and Stem Cell Derived Products in India
Stem Cell Science/Regenerative Medicine is perhaps the most important "pillar" out of the four pillars of modern medicine. Use and abuse of the "Stem Cells and Stem Cell derived Products" as therapeutic measure for treat...